Lifevantage PE Ratio 2010-2024 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of April 23, 2025 is 18.65.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-04-23 12.71 22.70
2024-12-31 17.49 $0.56 31.23
2024-09-30 12.02 $0.32 37.56
2024-06-30 6.36 $0.23 27.66
2024-03-31 5.96 $0.28 21.30
2023-12-31 5.88 $0.23 25.58
2023-09-30 6.29 $0.20 31.45
2023-06-30 4.00 $0.20 19.98
2023-03-31 3.27 $-0.06 0.00
2022-12-31 3.36 $-0.05 0.00
2022-09-30 3.37 $0.04 84.13
2022-06-30 3.87 $0.24 16.14
2022-03-31 4.21 $0.70 6.01
2021-12-31 5.59 $0.73 7.65
2021-09-30 5.99 $0.98 6.11
2021-06-30 6.50 $0.90 7.22
2021-03-31 8.27 $0.81 10.20
2020-12-31 8.24 $0.80 10.30
2020-09-30 10.67 $0.84 12.70
2020-06-30 11.95 $0.79 15.13
2020-03-31 9.11 $0.79 11.53
2019-12-31 13.80 $0.80 17.25
2019-09-30 12.11 $0.56 21.63
2019-06-30 11.47 $0.50 22.95
2019-03-31 12.63 $0.45 28.07
2018-12-31 11.66 $0.45 25.91
2018-09-30 9.72 $0.41 23.70
2018-06-30 5.63 $0.41 13.73
2018-03-31 3.19 $0.21 15.20
2017-12-31 4.21 $0.09 46.76
2017-09-30 3.73 $0.09 41.45
2017-06-30 3.83 $0.11 34.80
2017-03-31 4.75 $0.26 18.26
2016-12-31 7.20 $0.33 21.83
2016-09-30 8.36 $0.42 19.91
2016-06-30 12.02 $0.42 28.63
2016-03-31 8.04 $0.26 30.94
2015-12-31 8.42 $0.26 32.37
2015-09-30 5.01 $0.22 22.78
2015-06-30 3.28 $0.49 6.69
2015-03-31 4.89 $0.63 7.76
2014-12-31 8.04 $0.70 11.49
2014-09-30 7.05 $0.84 8.40
2014-06-30 8.91 $0.70 12.73
2014-03-31 8.11 $0.56 14.48
2013-12-31 10.21 $0.63 16.22
2013-09-30 14.73 $0.42 35.08
2013-06-30 14.36 $0.42 34.20
2013-03-31 14.54 $0.70 20.78
2012-12-31 13.55 $0.14 96.80
2012-09-30 21.23 $0.49 43.33
2012-06-30 17.51 $0.42 41.70
2012-03-31 23.27 $-3.78 0.00
2011-12-31 8.85 $-4.34 0.00
2011-09-30 9.28 $-4.27 0.00
2011-06-30 9.28 $-4.34 0.00
2011-03-31 4.39 $-0.98 0.00
2010-12-31 2.41 $-1.05 0.00
2010-09-30 3.09 $-1.54 0.00
2010-06-30 3.16 $-1.47 0.00
2010-03-31 2.41 $-1.68 0.00
2009-12-31 1.55 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.169B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26